Vitamin D Trajectories From Birth to Early Childhood and Elevated Systolic Blood Pressure During Childhood and Adolescence
Guoying Wang gwang24 at jhu.edu, Xin Liu , Tami R. Bartell , Colleen Pearson , Tina L. Cheng , Xiaobin Wang
Hypertension https://doi.org/10.1161/HYPERTENSIONAHA.119.13120Hypertension. ;0
- Hypertension associated with genes which reduce vitamin D – meta-analysis June 2014
- Hypertension 2X more likely when vitamin D levels lower than 14 ng – meta-analysis May 2012
Items in both categories Hypertension and Magnesium are listed here:
- Hypertension reduced by Magnesium plus 3,000 IU of vitamin D for 12 weeks – RCT July 2022
- More Magnesium needed to decrease diabetes, cardio, HT (body weight has increased) - March 2021
- Hypertension treatment needs at least 600 mg of Magnesium (49 trials) – Jan 2021
- The Role of Magnesium in the Pathogenesis of Metabolic Disorders – April 2022
- Reduce blood pressure by 9 mm with triple hypertensive drug or 19 mm with Magnesium – April 2018
- Hypertension nonconventional therapies: Magnesium, melatonin, Vitamin C, etc. – Jan 2018
- MAGNESIUM IN MAN - IMPLICATIONS FOR HEALTH AND DISEASE – review 2015
- Prehypertension risk is increased by 78% if low Magnesium – Aug 2015
- Preeclampsia inversely proportional to serum Magnesium – Oct 2014
- Hypertension 1.5X more likely if low level of Magnesium - Oct 2014
Items in both categories Hypertension and Infant-Child are listed here:
- Hypertension 2X more likely as a youth if low vitamin D for first 3 years of life – June 2019
- Child 49 percent higher risk of being overweight if preeclampsia during pregnancy – Sept 2017
- More Hypertension in obese children with low vitamin D, especially at night – Dec 2013
- Metabolic Syndrome in children is associated with low vitamin D – review Jan 2013
Vitamin D deficiency is associated with hypertension in adults. It is unknown to what degree vitamin D status in early life can affect blood pressure (BP) a decade later. This study investigated the effect of vitamin D trajectory through early life on systolic BP (SBP) in childhood. This is a prospective birth cohort study of 775 children enrolled from 2005 to 2012 and followed prospectively up to age 18 years at the Boston Medical Center, Boston, MA.
Persistent low vitamin D status is defined as plasma 25(OH)D <11 ng/mL at birth and <25 ng/mL in early childhood.
Elevated SBP is defined as SBP ≥75th percentile.
Low vitamin D status at birth was associated with higher risk of
- elevated SBP at ages 3 to 18 years: odds ratio, 1.38; (95% CI, 1.01–1.87) compared to those with sufficient vitamin D.
Low vitamin D status in early childhood was associated with a
- 1.59-fold (95% CI, 1.02–2.46) higher risk of elevated SBP at age 6 to 18 years.
Persistent low vitamin D status from birth to early childhood was associated with higher risk of elevated SBP (odds ratio,
- 2.04; [95% CI, 1.13–3.67]) at ages 3 to 18 years.
These results suggest that low vitamin D status and trajectory in early life were associated with increased risk of elevated SBP during childhood and adolescence. Our findings will help inform future clinical and public health strategies for vitamin D screening and supplementation in pregnancy and childhood to prevent or reduce risk of elevated BP across the lifespan and generations.